Valium and Rapamune drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Valium (diazepam) and Rapamune (sirolimus). Common drug interactions include kidney transplant rejection among females and diabetic coma among males.

The phase IV clinical study analyzes what interactions people have when they take Valium and Rapamune. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Valium?

Valium has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 48,647 Valium users. Check the latest studies of Valium.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.



On Jul, 22, 2026

29 people who take Valium and Rapamune together, and have interactions are studied.

Valium and Rapamune drug interactions.

What are the common drug interactions of Valium and Rapamune, by gender? *:

female:

  1. Kidney transplant rejection
  2. Drug ineffective
  3. Diarrhoea
  4. Hypertension (high blood pressure)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Anaemia (lack of blood)
  7. Decreased appetite
  8. Dysgeusia (disorder of the sense of taste)
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Dysphonia (speech disorder attributable to a disorder of phonation)

male:

  1. Diabetic coma
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Haemoglobin decreased
  4. Hypogeusia (reduced ability to taste things (to taste sweet, sour, bitter, or salty substances))
  5. Libido decreased (loss of interest in sex)
  6. Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein)
  7. Neurological symptom (symptoms of nervous system disease)
  8. Optic atrophy (the loss of a proportion of optic disc nerve fibres)
  9. Optic neuritis (optic nerve inflammation)
  10. Papillitis (inflammation of the optic nerve head)

What are the common drug interactions of Valium and Rapamune, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Cardiac failure
  2. Microangiopathy (disease of the capillaries (very small blood vessels), in which the capillary walls become so thick and weak that they bleed, leak protein)

20-29:

  1. Death
  2. Leukopenia (less number of white blood cells in blood)

30-39:

  1. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  2. Hypophagia (reduced food intake)
  3. Nausea (feeling of having an urge to vomit)
  4. Weight decreased
  5. Activated partial thromboplastin time prolonged
  6. Blood bilirubin increased
  7. Blood fibrinogen increased
  8. Haemoglobin decreased
  9. Haemorrhagic stroke (stroke caused by the rupture of a blood vessel in the brain)
  10. Heart rate increased

40-49:

  1. Diabetic coma
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Blindness
  4. Death
  5. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

50-59:

  1. Kidney transplant rejection
  2. Blindness
  3. Drug ineffective
  4. Gait disturbance
  5. Neurological symptom (symptoms of nervous system disease)
  6. Visual disturbance
  7. Abdominal discomfort
  8. Blood creatine phosphokinase increased
  9. Blood pressure inadequately controlled
  10. Blood pressure increased

60+:

  1. Headache (pain in head)
  2. Anaemia (lack of blood)
  3. Hypertension (high blood pressure)
  4. Pruritus (severe itching of the skin)
  5. Sinus disorder (disease of sinus)
  6. Swollen tongue (swelling of tongue)
  7. Weight decreased
  8. Drug ineffective
  9. Drug resistance (reduction in effectiveness of a drug)
  10. Herpes zoster

What are the existing conditions these people have? *

  1. Pain: 6 people, 20.69%
  2. Immunodeficiency Disorders: 4 people, 13.79%
  3. High Blood Pressure: 3 people, 10.34%
  4. Insomnia (sleeplessness): 2 people, 6.90%
  5. Depression: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Valium and Rapamune?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Valium and Rapamune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Valium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Rapamune:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Valium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rapamune and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diazepam and sirolimus (the active ingredients of Valium and Rapamune, respectively), and Valium and Rapamune (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: